A PHASE-II TRIAL OF IFOSFAMIDE, 5-FLUOROURACIL, AND LEUCOVORIN IN RECURRENT UTERINE CERVICAL-CANCER

被引:10
|
作者
STORNES, I
MEJLHOLM, I
JAKOBSEN, A
机构
[1] Department of Oncology, Aarhus University Hospital
关键词
D O I
10.1006/gyno.1994.1260
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Thirty patients with recurrent squamous cell carcinoma of cervix uteri no longer amenable to control with surgery and/or radiotherapy were treated with a combination of ifosfamide, 5-fluorouracil, and Leucovorin every 4 weeks. The response rate was 53% (complete response, 33%; partial response, 20%). Response rates outside and inside irradiated area were 68 and 27%, respectively. The median progression-free interval was 7 months, and the median overall survival was 12 months. Adverse effects included primarily leukopenia, and dose reduction was necessary in 18 patients (60%). The present combination is active in the treatment of recurrent cervical cancer with a high response rate. The long-term survival is however still unsatisfactory. (C) 1994 Academic Press, Inc.
引用
收藏
页码:123 / 125
页数:3
相关论文
共 50 条
  • [41] 5-FLUOROURACIL AND LOW-DOSE LEUCOVORIN IN THE TREATMENT OF RECURRENT EPITHELIAL OVARIAN-CARCINOMA - A PHASE-II TRIAL OF THE GYNECOLOGIC-ONCOLOGY-GROUP
    LOOK, KY
    BLESSING, JA
    MUSS, HB
    DEGEEST, K
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1992, 15 (06): : 494 - 496
  • [42] Phase II clinical trial of 5-fluorouracil, trimetrexate, and leucovorin (NFL) in patients with advanced pancreatic cancer
    Agustin A. Garcia
    Lawrence Leichman
    Joaquina Baranda
    Lalita Pandit
    Heinz-Josef Lenz
    Cynthia G. Leichman
    International Journal of Gastrointestinal Cancer, 2003, 34 (2-3): : 79 - 86
  • [43] PHASE-II TRIAL OF 5-FLUOROURACIL, ADRIAMYCIN AND CISPLATIN (FAP) FOLLOWED BY RADIATION AND 5-FLUOROURACIL IN LOCALLY ADVANCED PANCREATIC-CANCER
    WAGENER, DJT
    VANHOESEL, QGCM
    YAP, SH
    HOOGENRAAD, WJ
    WOBBES, T
    STRIJK, SP
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1989, 25 (02) : 131 - 134
  • [44] PHASE-II TRIAL OF IFOSFAMIDE IN RECURRENT AND METASTATIC HEAD AND NECK-CANCER
    BUESA, JM
    FERNANDEZ, R
    ESTEBAN, E
    ESTRADA, E
    BARON, FJ
    PALACIO, I
    GRACIA, M
    LACAVE, AJ
    ANNALS OF ONCOLOGY, 1991, 2 (02) : 151 - 152
  • [45] A PHASE-II TRIAL OF TAMOXIFEN, PREMARIN, METHOTREXATE AND 5-FLUOROURACIL IN METASTATIC BREAST-CANCER
    ALLEGRA, J
    WOODCOCK, T
    STEVENS, D
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1986, 22 (06): : 728 - 728
  • [46] PHASE-II TRIAL OF 5-FLUOROURACIL AND FOLINIC ACID IN THE TREATMENT OF ADVANCED BREAST-CANCER
    FINE, S
    ERLICHMAN, C
    KAIZER, L
    WARR, D
    GADALLA, T
    BREAST CANCER RESEARCH AND TREATMENT, 1994, 30 (02) : 205 - 209
  • [47] Phase II study of gemcitabine, 5-fluorouracil, and leucovorin in patients with pancreatic cancer
    Marantz, A
    Jovtis, S
    Almira, E
    Balbiani, L
    Castilla, JL
    Fein, L
    Lewi, D
    Pasccon, G
    Pinckevicius, R
    Uranga, G
    Abal, M
    Muiño, M
    Reale, M
    Agusto, S
    Lastiri, F
    SEMINARS IN ONCOLOGY, 2001, 28 (03) : 44 - 49
  • [48] PHASE-II TRIAL OF 5-FLUOROURACIL, ADRIAMYCIN, AND MITOMYCIN-C IN ADVANCED COLORECTAL CANCER
    HALLER, DG
    WOOLLEY, PV
    MACDONALD, JS
    SMITH, LF
    SCHEIN, PS
    CANCER TREATMENT REPORTS, 1978, 62 (04): : 563 - 565
  • [49] PHASE-II TRIAL OF 5-FLUOROURACIL, ADRIAMYCIN AND CISPLATIN (FAP) IN ADVANCED GASTRIC-CANCER
    WAGENER, DJT
    YAP, SH
    WOBBES, T
    BURGHOUTS, JTM
    VANDAM, FE
    HILLEN, HFP
    HOOGENDOORN, GJ
    SCHEERDER, H
    VANDERVEGT, SGL
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1985, 15 (01) : 86 - 87
  • [50] Oral doxifluridine plus leucovorin in metastatic colorectal cancer - Randomized phase II trial with intravenous 5-fluorouracil plus leucovorin
    Ahn, JH
    Kim, TW
    Lee, JH
    Min, YJ
    Kim, JG
    Kim, JC
    Yu, CS
    Kim, WK
    Kang, YK
    Lee, JS
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2003, 26 (01): : 98 - 102